drugset / Trial / NCT02108483

Phototoxicity Test of Dapsone Gel in Healthy Volunteers

NCT02108483

Phase 1 Completed 33 enrolled Almirall, S.A. Allergan · collab
NaSingle-groupTriple-blindTreatment

Summary

This study will evaluate the potential of dapsone gel and its vehicle to cause a phototoxic reaction following irradiation of the skin under controlled conditions.

Timeline

Start
2014-04
Primary completion
2014-05
Completion
2014-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapsone Small molecule

Indications

No indication recorded.